Ibukern

Ibuprofen, the active ingredient in Ibukern, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats pain, fever and inflammation in adults and children as directed by a healthcare professional.

GNH USA supplies Ibukern as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that reduces pain, fever and inflammation by inhibiting cyclooxygenase enzymes.

- Pain: provides analgesic relief for mild to moderate acute or chronic pain. - Fever: lowers elevated body temperature in febrile conditions. - Arthritis: reduces joint inflammation and stiffness in osteoarthritis and rheumatoid arthritis.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastro‑intestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache or dizziness. - Mild skin rash or pruritus. - Diarrhoea or constipation. - Transient elevation of liver enzymes.

Serious or Rare Side Effects: - Gastro‑intestinal ulceration or bleeding. - Acute renal impairment or failure. - Severe hypersensitivity reactions, including anaphylaxis. - Hepatotoxicity with marked transaminase rise. - Cardiovascular events such as myocardial infarction or stroke. - Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating ibuprofen therapy, consider patient‑specific risk factors and follow safe handling guidelines.

- Assess renal function: avoid or adjust dose in patients with significant renal impairment. - Evaluate gastrointestinal risk: use cautiously in individuals with a history of ulcer or GI bleeding. - Monitor cardiovascular status: employ with caution in patients with established heart disease. - Avoid use in the third trimester of pregnancy: contraindicated due to fetal risks. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Ibuprofen may interact with several drug classes; awareness of the interaction severity guides clinical decisions.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Concurrent NSAIDs: additive gastrointestinal toxicity. - Corticosteroids: heightened ulcer risk. - ACE inhibitors or ARBs: potential reduction in renal function. - Lithium: elevated serum lithium concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: may impair renal clearance of ibuprofen. - Methotrexate: increased toxicity at high doses. - SSRIs or SNRIs: modestly increased bleeding tendency. - Antihypertensives: possible attenuation of blood‑pressure‑lowering effect. - Allopurinol: rare reports of severe skin reactions.